About the Company
We do not have any company description for VERU INC. at the moment.
Exchange
Nasdaq
Fundamental Data and Insider Transactions (Quarterly data) Full Screen
Loading the fundamentals chart...
Latest $VERU News
Veru Inc (VERU) Stock: A Look at the Analyst Recommendations
To put it simply, Veru Inc (VERU) has had a better performance in recent times. Analysts have a bullish opinion on the stock, with some rating it as a “buy” and others as a “hold”. It is worth ...
Veru Inc
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings ...
3 Standout Penny Stocks to Watch This April
Investing in penny stocks \- generally, stocks that trade for less than $5 per share or have small market caps and low floats ...
What Makes Veru (VERU) a New Buy Stock
Veru Inc. (VERU) could be a solid addition to your portfolio given its recent upgrade to a Zacks Rank #2 (Buy). This rating change essentially reflects an upward trend in earnings estimates -- one ...
Veru Stock (NASDAQ:VERU), Analyst Ratings, Price Targets, Predictions
$1.28 1775% HC Wainwright & Co.
Veru Inc (VERU) Volatility Hits 16.29% – Here Is What You Should Do
Veru Inc (NASDAQ:VERU) concluded the trading at $1.24 Wednesday, April 10, with a rise of 5.98% from its closing price on previous day. Taking a look at stock we notice that its last check on previous ...
VERU Apr 2024 1.000 put
2023 Form 10-K/A and Q1 2024 Form 10-Q filed today-- --2024 Annual Meeting of Shareholders will be June 18, 2024 -- MIAMI, FL, April 01, 2024 (GLOBE NEWSWIRE) -- Veru Inc. (NASDAQ: VERU), a late ...
Veru Announces the Appointment of Louis Aronne MD as Chief Medical Advisor for its Enobosarm Program for High Quality Weight Loss
MIAMI, March 12, 2024 (GLOBE NEWSWIRE) -- Veru Inc. (NASDAQ: VERU), a late clinical stage biopharmaceutical company focused on developing innovative medicines for preserving muscle for high ...
Veru Reschedules Annual Meeting of Shareholders
--Restated historical financial statements expected to be filed no later than April 15, 2024-- --2024 Annual Meeting of Shareholders to follow financial statements filings-- MIAMI, FL, March 22 ...
Veru Stock (NASDAQ:VERU), Quotes and News Summary
Here Are Other Stocks Moving In Monday's Mid-Day Session Shares of Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) fell sharply during Monday’s session after the company revealed new data from the ...
Loading the latest forecasts...